Based on the provided abstracts, there appears to be confusion between two different protein complexes both abbreviated as PRC1. The abstracts primarily discuss Polycomb Repressive Complex 1 (PRC1), a chr15-regulating complex involved in gene silencing, rather than the cytokinesis regulator specified in the gene description. Polycomb PRC1 functions as a histone H2A E3 ubiquitin ligase that catalyzes monoubiquitylation of histone H2A at lysine 119 (H2AK119Ub) 1. This complex maintains gene silencing by compacting chr15 and works in conjunction with PRC2, which methylates histone H3 at lysine 27 2. PRC1 demonstrates a read-write mechanism where it recognizes existing H2AK119Ub modifications and establishes new ones through asymmetrical nucleosome binding 3. In hematopoiesis, PRC1 complexes maintain cell identity during differentiation and are frequently mutated in hematological malignancies 4. The complex also plays roles in cancer progression, driving metastasis in prostate cancer by coordinating stemness with immune suppression 5, and has been identified as a potential biomarker in hepatocellular carcinoma 6. Additionally, RING1, a PRC1 component, regulates inflammatory responses by promoting GSDMD degradation 7. However, insufficient information is provided about the cytokinesis-specific PRC1 protein mentioned in the gene description.